Literature DB >> 19221879

Is drug release necessary for antimicrobial activity of siderophore-drug conjugates? Syntheses and biological studies of the naturally occurring salmycin "Trojan Horse" antibiotics and synthetic desferridanoxamine-antibiotic conjugates.

Timothy A Wencewicz1, Ute Möllmann, Timothy E Long, Marvin J Miller.   

Abstract

The recent rise in drug resistance found amongst community acquired infections has sparked renewed interest in developing antimicrobial agents that target resistant organisms and limit the natural selection of immune variants. Recent discoveries have shown that iron uptake systems in bacteria and fungi are suitable targets for developing such therapeutic agents. The use of siderophore-drug conjugates as "Trojan Horse" drug delivery agents has attracted particular interest in this area. This review will discuss efforts in our research group to study the salmycin class of "Trojan Horse" antibiotics. Inspired by the natural design of the salmycins, a series of desferridanoxamine-antibiotic conjugates were synthesized and tested in microbial growth inhibition assays. The results of these studies will be related to understanding the role of drug release in siderophore-mediated drug delivery with implications for future siderophore-drug conjugate design.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19221879      PMCID: PMC2766516          DOI: 10.1007/s10534-009-9218-3

Source DB:  PubMed          Journal:  Biometals        ISSN: 0966-0844            Impact factor:   2.949


  46 in total

1.  Screening system for xenosiderophores as potential drug delivery agents in mycobacteria.

Authors:  G Schumann; U Möllmann
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

2.  The bacteria fight back.

Authors:  Gary Taubes
Journal:  Science       Date:  2008-07-18       Impact factor: 47.728

3.  Investigations of the MceIJ-catalyzed posttranslational modification of the microcin E492 C-terminus: linkage of ribosomal and nonribosomal peptides to form "trojan horse" antibiotics.

Authors:  Elizabeth M Nolan; Christopher T Walsh
Journal:  Biochemistry       Date:  2008-08-09       Impact factor: 3.162

4.  Synthesis and activities of pyoverdin-quinolone adducts: a prospective approach to a specific Therapy against Pseudomonas aeruginosa.

Authors:  C Hennard; Q C Truong; J F Desnottes; J M Paris; N J Moreau; M A Abdallah
Journal:  J Med Chem       Date:  2001-06-21       Impact factor: 7.446

5.  Clonal dissemination of two MRSA strains in Germany.

Authors:  W Witte; C Cuny; C Braulke; D Heuck
Journal:  Epidemiol Infect       Date:  1994-08       Impact factor: 2.451

6.  Constitution of ferrimycin A1.

Authors:  H Bickel; P Mertens; V Prelog; J Seibl; A Walser
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1965

7.  Identification and characterization of porins in Pseudomonas aeruginosa.

Authors:  H Nikaido; K Nikaido; S Harayama
Journal:  J Biol Chem       Date:  1991-01-15       Impact factor: 5.157

8.  Intracellular activation of albomycin in Escherichia coli and Salmonella typhimurium.

Authors:  V Braun; K Günthner; K Hantke; L Zimmermann
Journal:  J Bacteriol       Date:  1983-10       Impact factor: 3.490

9.  Modes of action and inhibitory activities of new siderophore-beta-lactam conjugates that use specific iron uptake pathways for entry into bacteria.

Authors:  A Brochu; N Brochu; T I Nicas; T R Parr; A A Minnick; E K Dolence; J A McKee; M J Miller; M C Lavoie; F Malouin
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

10.  Penetration of beta-lactam antibiotics into their target enzymes in Pseudomonas aeruginosa: comparison of a highly sensitive mutant with its parent strain.

Authors:  W Zimmermann
Journal:  Antimicrob Agents Chemother       Date:  1980-07       Impact factor: 5.191

View more
  21 in total

Review 1.  Signed, Sealed, Delivered: Conjugate and Prodrug Strategies as Targeted Delivery Vectors for Antibiotics.

Authors:  Ana V Cheng; William M Wuest
Journal:  ACS Infect Dis       Date:  2019-04-10       Impact factor: 5.084

2.  Siderophore-fluoroquinolone conjugates containing potential reduction-triggered linkers for drug release: synthesis and antibacterial activity.

Authors:  Cheng Ji; Marvin J Miller
Journal:  Biometals       Date:  2015-02-08       Impact factor: 2.949

3.  New Synthetic Approach for the Incorporation of 3,2-Hydroxypyridinone (HOPO) Ligands: Synthesis of Structurally Diverse Poly HOPO Chelators.

Authors:  Jayanthi Arumugam; Hayley A Brown; Hollie K Jacobs; Aravamudan S Gopalan
Journal:  Synthesis (Stuttg)       Date:  2011-01-01       Impact factor: 3.157

4.  Esterase-Catalyzed Siderophore Hydrolysis Activates an Enterobactin-Ciprofloxacin Conjugate and Confers Targeted Antibacterial Activity.

Authors:  Wilma Neumann; Martina Sassone-Corsi; Manuela Raffatellu; Elizabeth M Nolan
Journal:  J Am Chem Soc       Date:  2018-04-10       Impact factor: 15.419

Review 5.  Exploiting bacterial iron acquisition: siderophore conjugates.

Authors:  Cheng Ji; Raúl E Juárez-Hernández; Marvin J Miller
Journal:  Future Med Chem       Date:  2012-03       Impact factor: 3.808

6.  Chemical syntheses and in vitro antibacterial activity of two desferrioxamine B-ciprofloxacin conjugates with potential esterase and phosphatase triggered drug release linkers.

Authors:  Cheng Ji; Marvin J Miller
Journal:  Bioorg Med Chem       Date:  2012-05-02       Impact factor: 3.641

7.  The Pseudomonas aeruginosa PA14 ABC Transporter NppA1A2BCD Is Required for Uptake of Peptidyl Nucleoside Antibiotics.

Authors:  Daniel Pletzer; Yvonne Braun; Svetlana Dubiley; Corinne Lafon; Thilo Köhler; Malcolm G P Page; Michael Mourez; Konstantin Severinov; Helge Weingart
Journal:  J Bacteriol       Date:  2015-04-27       Impact factor: 3.490

8.  Biscatecholate-monohydroxamate mixed ligand siderophore-carbacephalosporin conjugates are selective sideromycin antibiotics that target Acinetobacter baumannii.

Authors:  Timothy A Wencewicz; Marvin J Miller
Journal:  J Med Chem       Date:  2013-05-08       Impact factor: 7.446

9.  Trihydroxamate siderophore-fluoroquinolone conjugates are selective sideromycin antibiotics that target Staphylococcus aureus.

Authors:  Timothy A Wencewicz; Timothy E Long; Ute Möllmann; Marvin J Miller
Journal:  Bioconjug Chem       Date:  2013-02-14       Impact factor: 4.774

10.  Diverted Total Synthesis of Promysalin Analogs Demonstrates That an Iron-Binding Motif Is Responsible for Its Narrow-Spectrum Antibacterial Activity.

Authors:  Andrew D Steele; Colleen E Keohane; Kyle W Knouse; Sean E Rossiter; Sierra J Williams; William M Wuest
Journal:  J Am Chem Soc       Date:  2016-04-28       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.